ACAT-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of ACAT-1 monoclonal antibodies for research focused on acyl-CoA:cholesterol acyltransferase 1. ACAT-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACAT-1 is crucial for cholesterol metabolism, playing a significant role in the esterification of free cholesterol to form cholesteryl esters, which are essential for lipid homeostasis and cellular function. Dysregulation of ACAT-1 has been implicated in various diseases, including atherosclerosis and neurodegenerative disorders, making it an important target for therapeutic intervention. Understanding the function of ACAT-1 can provide insights into lipid-related diseases and potential treatment strategies. ACAT-1 monoclonal antibodies enable precise investigation of cholesterol metabolism pathways in cellular systems. Researchers worldwide rely on ACAT-1 monoclonal antibodies to advance scientific understanding of lipid metabolism and its role in human health. Santa Cruz Biotechnology monoclonal antibodies support breakthrough discoveries in cholesterol metabolism research, contributing to the advancement of therapeutic strategies for metabolic disorders.